The fundamental problem in terms of toxicity of the therapies that target the EGFR is the appearance of severe rash, infiltrated lymphocytes, folliculitis, and other adverse reactions that can cause in kidney cells and gastrointestinal mucosa. Here, EGFR is linked to folliculitis.